DIVISLAB's weekly performance was strong, with a 1.53% return, outperforming its peers DRREDDY and SUNPHARMA. The stock's volatility was moderate at 11.47%, lower than its peers except SUNPHARMA. With a Sharpe Ratio of 0.53, DIVISLAB demonstrated a relatively stable performance, and its Max Drawdown of -0.19% suggests a low risk profile. Overall, DIVISLAB was a relatively safe and profitable bet this week.

[Volatility: 11.47%]